[March 07, 2013]

Research and Markets: North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Research and Markets (http://www.researchandmarkets.com/research/qqscb7/north_america) has announced the addition of GlobalData's new report "North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering.

This new report, North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the North America Drug Delivery Devices market - United States and Canada. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Scope

- Countries covered include United States and Canada.

- Market size and company share data for Drug Delivery Devices market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injctions.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the North America Drug Delivery Devices market.

- Key players covered include GlaxoSmithKline plc, Hospira, Inc., CareFusion Corporation, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc., Medtronic, Inc., Teleflex Incorporated, Smiths Medical, Fresenius Kabi AG and B. Braun Melsungen AG.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the North America Drug Delivery Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Drug Delivery Devices in North America

4 Drug Delivery Devices In United States

5 Drug Delivery Devices In Canada

6 Overview of Key Companies in North America Drug Delivery Devices Market

7 Drug Delivery Devices Market Pipeline Products

8 Financial Deals Landscape

9 Recent Developments

10 Appendix

Companies Mentioned

- GlaxoSmithKline plc

- Hospira, Inc.

- CareFusion Corporation

- Boehringer Ingelheim GmbH

- AstraZeneca PLC

- Baxter International Inc.

- Medtronic, Inc.

- Teleflex Incorporated

- Smiths Medical

- Fresenius Kabi AG

- B. Braun Melsungen AG

- Terumo Corporation

- C. R. Bard, Inc.

- 3M (News - Alert) Health Care Ltd.

- Sunovion Pharmaceuticals Inc.

- Consort Medical plc

- Edwards Lifesciences Corporation

- Becton, Dickinson and Company

- INJEX - Equidyne Systems

- Bioject Medical Technologies Inc.

- Antares Pharma, Inc.

- Cook Medical Incorporated

- PharmaJet, Inc.

For more information visit http://www.researchandmarkets.com/research/qqscb7/north_america

Source (News - Alert): GlobalData

[ Back To Technology News's Homepage ]